Compare PRK & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRK | VCYT |
|---|---|---|
| Founded | 1908 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.1B |
| IPO Year | 1996 | 2013 |
| Metric | PRK | VCYT |
|---|---|---|
| Price | $176.67 | $47.86 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $184.00 | $44.00 |
| AVG Volume (30 Days) | 65.4K | ★ 1.1M |
| Earning Date | 04-24-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | 19.21 | ★ 164.52 |
| EPS | ★ 2.39 | 0.35 |
| Revenue | ★ $664,421,000.00 | N/A |
| Revenue This Year | $24.26 | $13.76 |
| Revenue Next Year | $3.63 | $12.35 |
| P/E Ratio | ★ $73.79 | $137.63 |
| Revenue Growth | ★ 2.92 | N/A |
| 52 Week Low | $149.06 | $22.61 |
| 52 Week High | $179.70 | $50.71 |
| Indicator | PRK | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 62.18 | 60.96 |
| Support Level | $168.79 | $41.03 |
| Resistance Level | N/A | $50.63 |
| Average True Range (ATR) | 3.33 | 2.23 |
| MACD | 0.77 | -0.22 |
| Stochastic Oscillator | 77.82 | 60.35 |
Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. The company provides the following principal services: the acceptance of deposits for demand, savings and time accounts; commercial, industrial, consumer and real estate lending, including installment loans, credit cards (which are largely offered through a third party), home equity lines of credit and commercial leasing; trust and wealth management services; cash management; safe deposit operations; electronic funds transfers; and a variety of additional banking-related services.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).